Identification of circulating tumor cells using 4‐color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low‐dose computed tomography–detected lung nodules-Reference-Cited by-同舟云学术

Identification of circulating tumor cells using 4‐color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low‐dose computed tomography–detected lung nodules

Published:2020-04-22 Issue:8 Volume:128 Page:553-562
ISSN:1934-662X
Container-title:Cancer Cytopathology
language:en
Short-container-title:Cancer Cytopathol

Author:

Katz Ruth L.¹,Zaidi Tanweer M.¹,Pujara Deep²,Shanbhag Namita D.¹,Truong Duy¹,Patil Shekhar³,Mehran Reza J.¹⁴,El‐Zein Randa A.¹⁵,Shete Sanjay S.¹⁶,Kuban Joshua D.¹⁷

Affiliation:

1. Department of Pathology The University of Texas MD Anderson Cancer Center Houston Texas

2. Department of Neurology McGovern Medical School at The University of Texas Health Science Center at Houston Houston Texas

3. Department of Internal Medicine McGovern Medical School at The University of Texas Health Science Center at Houston Houston Texas

4. Department of Thoracic and Cardiovascular Surgery The University of Texas MD Anderson Cancer Center Houston Texas

5. Department of Radiology Houston Methodist Research Institute Houston Texas

6. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston Texas

7. Department of Interventional Radiology The University of Texas MD Anderson Cancer Center Houston Texas

Funder

Thermo Fisher Scientific

National Cancer Institute

Division of Cancer Prevention, National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncy.22278

Reference26 articles.

1. NooneA HowladerN KrapchoM et al.SEER Cancer Statistics Review (CSR) 1975‐2015. November 2017 SEER data submission published April 2018.https://seer.cancer.gov/csr/1975_2016/

2. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

3. Recent Trends in the Identification of Incidental Pulmonary Nodules

4. Management of Pulmonary Nodules by Community Pulmonologists

5. Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims Analysis

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers;Journal of Clinical Medicine;2023-11-23

2. Recent advances of liquid biopsy: Interdisciplinary strategies toward clinical decision‐making;Interdisciplinary Medicine;2023-10

3. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules;BMC Pulmonary Medicine;2023-06-05

4. A Lightweight and Robust Framework for Circulating Genetically Abnormal Cells (CACs) Identification Using 4-Color Fluorescence In Situ Hybridization (FISH) Image and Deep Refined Learning;Journal of Digital Imaging;2023-05-25

5. The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis;Technology in Cancer Research & Treatment;2023-01